Prevalence of Anti-JC Virus (JCV) Antibodies in the Multiple Sclerosis (MS) Population in Cyprus: A Retrospective Study

Figure 1

Anti-JCV antibody prevalence by patient demographics: (a) gender and (b) age. The number of patients in each group is shown in the legend of each bar, and vertical bars represent 95% confidence intervals. The ^$ value comparing seroprevalence across all demographic variable categories was determined from univariate logistic regression analysis with anti-JVC seropositivity as the outcome. The ^£ value comparing each age group with the baseline (age ≤ 29) was determined from univariate logistic regression analysis with anti-JVC seropositivity as the outcome. Statistically significant value.

(a)

(b)